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2010-2011 Influenza Season 
Week 11 ending March 19, 2011 
All data are preliminary and may change as more reports are received. 
 
Synopsis: During week 11 (March 13-19, 2011), influenza activity in the United States decreased.  
o Of the 6,144 specimens tested by U.S. World Health Organization (WHO) and National 
Respiratory and Enteric Virus Surveillance System (NREVSS) collaborating laboratories and 
reported to CDC/Influenza Division, 1,158 (18.9%) were positive for influenza. 
o The proportion of deaths attributed to pneumonia and influenza (P&I) was at or above the 
epidemic threshold for the eighth consecutive week. 
o Six influenza-associated pediatric deaths were reported bringing the season total to 77. Two 
of these deaths were associated with influenza B viruses, two were associated with 
influenza A (H3N2) viruses, one was associated with 2009 influenza A (H1N1) virus, and 
one was associated with an influenza A virus for which the subtype was not determined. 
o The proportion of outpatient visits for influenza-like illness (ILI) was at the national baseline 
of 2.5%. Six of the 10 regions (Regions 1, 2, 5, 7, 8, and 10) reported ILI at or above region-
specific baseline levels. One state experienced high ILI activity; two states experienced 
moderate ILI activity; 11 states experienced low ILI activity; 35 states and New York City 
experienced minimal ILI activity, and the District of Columbia and one state had insufficient 
data. 
o The geographic spread of influenza in 18 states was reported as widespread; 22 states 
reported regional influenza activity; the District of Columbia and seven states reported local 
influenza activity; Guam, Puerto Rico, the U.S. Virgin Islands and three states reported 
sporadic influenza activity. 
 
National and Regional Summary of Select Surveillance Components 
 Data for current week Data cumulative since October 3, 2010 (Week 40) 
HHS 
Surveillance 
Regions* 
Out-
patient 
ILI† 
% 
positive 
for flu‡ 
Number of  
jurisdictions 
reporting 
regional or 
widespread 
activity§ 
A (H3) 
2009 A 
(H1N1) 
A 
(Subtyping not 
performed) 
B 
Pediatric 
Deaths 
Nation Elevated 18.9% 40 of 54 15,047 9,381 10,543 12,033 77 
Region 1 Elevated 38.2% 6 of 6 1,571 808 71 297 2 
Region 2 Elevated 22.3% 2 of 4 623 296 1,004 301 8 
Region 3 Normal 27.4% 4 of 6 2,755 2,462 793 776 10 
Region 4 Normal 15.1% 4 of 8 1,257 1,214 3,029 3,683 14 
Region 5 Elevated 42.7% 4 of 6 1,696 1,284 347 1,007 14 
Region 6 Normal 17.5% 4 of 5 2,136 517 2,259 2,518 16 
Region 7 Elevated 23.4% 4 of 4 657 511 269 616 0 
Region 8 Elevated 21.6% 5 of 6 1,660 618 1,932 1,659 4 
Region 9 Normal 21.9% 4 of 5 1,804 1,077 716 1,077 8 
Region 10 Elevated 29.3% 3 of 4 888 594 123 99 1 
*HHS regions (Region 1 CT, ME, MA, NH, RI, VT; Region 2: NJ, NY, Puerto Rico, U.S. Virgin Islands; Region 3: DE, DC, MD, PA, VA, WV; Region 4: AL, FL, GA, KY, MS, NC, 
SC, TN; Region 5: IL, IN, MI, MN, OH, WI; Region 6: AR, LA, NM, OK, TX; Region 7: IA, KS, MO, NE; Region 8: CO, MT, ND, SD, UT, WY; Region 9: AZ, CA, Guam, HI, NV; 
and Region 10: AK, ID, OR, WA). 
† Elevated means the % of visits for ILI is at or above the national or region-specific baseline. 
‡ National data are for current week; regional data are for the most recent three weeks. 
§ Includes all 50 states, the District of Columbia, Guam, Puerto Rico, and the U.S. Virgin Islands. 
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U.S. Virologic Surveillance: WHO and NREVSS collaborating laboratories located in all 50 states 
and Washington D.C. report to CDC the number of respiratory specimens tested for influenza and 
the number positive by influenza type and subtype. The results of tests performed during the 
current week are summarized in the table below. 
 
 Week 11 
No. of specimens tested 6,144 
No. of positive specimens (%) 1,158 (18.9%) 
Positive specimens by type/subtype  
Influenza A 835 (72.1%) 
          A (2009 H1N1)   237 (28.4%)             
          A (subtyping not performed)          282 (33.8%) 
          A (H3)                316 (37.8%)     
Influenza B 323 (27.9%) 
 
All influenza types and subtypes have been identified at high levels this season and continue to 
circulate widely. The predominant virus has varied by week, region, and even between states within 
the same region. 
 
Influenza Positive Tests Reported to CDC by U.S. WHO/NREVSS 
Collaborating Laboratories, National Summary, 2010-11 Season 
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Aggregate Hospitalization and Death Reporting Activity (AHDRA): This system tracks weekly 
counts of laboratory-confirmed influenza-associated hospitalizations and deaths and was 
implemented on August 30, 2009, during the 2009 pandemic, and ended on April 4, 2010. AHDRA 
surveillance during the 2010-11 season is being continued on a voluntary basis and 16 jurisdictions 
reported during week 11. From October 3, 2010 – March 19, 2011, 13,945 laboratory-confirmed 
influenza associated hospitalizations and 253 laboratory-confirmed influenza associated deaths 
were reported to CDC. 
  
Weekly Laboratory-Confirmed Influenza-Associated Hospitalizations and 
Deaths, National Summary, 2010-11 Season 
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Antigenic Characterization: CDC has antigenically characterized 1,304 influenza viruses [240 
2009 influenza A (H1N1) viruses, 626 influenza A (H3N2) viruses, and 438 influenza B viruses] 
collected by U.S. laboratories since October 1, 2010. 
2009 Influenza A (H1N1) [240] 
 Two hundred thirty-nine (99.6%) of the 240 tested were characterized as 
A/California/7/2009-like, the influenza A (H1N1) component of the 2010-11 influenza 
vaccine for the Northern Hemisphere. One virus (0.4%) of the 240 tested showed 
reduced titers with antiserum produced against A/California/7/2009. 
 
Influenza A (H3N2) [626] 
 Six hundred six (96.8%) of the 626 tested were characterized as A/Perth/16/2009-
like, the influenza A (H3N2) component of the 2010-11 influenza vaccine for the 
Northern Hemisphere. Twenty viruses (3.2%) of the 626 tested showed reduced 
titers with antiserum produced against A/Perth/16/2009. 
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Influenza B (B/Victoria/02/87 and B/Yamagata/16/88 lineages) [438] 
Victoria Lineage [412] 
 Four hundred twelve (94.1%) of the 438 influenza B viruses tested belong to the 
B/Victoria lineage of viruses. 
o Four hundred eleven (99.8%) of these 412 viruses were characterized as 
B/Brisbane/60/2008-like, the recommended influenza B component for the 
2010-11 Northern Hemisphere influenza vaccine. 
o One (0.2%) of these 412 viruses showed somewhat reduced titers with 
antisera produced against B/Brisbane/60/2008. 
Yamagata Lineage [26] 
 Twenty-six (5.9%) of the 438 viruses were identified as belonging to the B/Yamagata 
lineage of viruses. 
Antiviral Resistance: Testing of 2009 influenza A (H1N1), influenza A (H3N2), and influenza B 
virus isolates for resistance to neuraminidase inhibitors (oseltamivir and zanamivir) is performed at 
CDC using a functional assay. Additional 2009 influenza A (H1N1) clinical samples are tested for a 
single known mutation in the neuraminidase protein of the virus that confers oseltamivir resistance 
(H275Y). The data summarized in the table below combine the results of both test methods and 
includes samples that were tested as part of routine surveillance purposes; it does not include 
diagnostic testing specifically done because of clinical suspicion of antiviral resistance. 
High levels of resistance to the adamantanes (amantadine and rimantadine) persist among 2009 
influenza A (H1N1) and A (H3N2) viruses (the adamantanes are not effective against influenza B 
viruses) circulating globally. As a result of the sustained high levels of resistance, data from 
adamantane resistance testing are not presented weekly in the table below.    
Neuraminidase Inhibitor Resistance Testing Results 
on Samples Collected Since October 1, 2010. 
 
Virus 
Samples 
tested (n) 
Resistant 
Viruses, 
Number (%) 
Virus 
Samples 
tested (n) 
Resistant 
Viruses, 
Number (%) 
Oseltamivir Zanamivir 
Seasonal 
Influenza A 
(H1N1) 
0 0 (0.0) 0 0 (0.0) 
Influenza A 
(H3N2) 
471 0 (0.0) 471 0 (0.0) 
Influenza B 461 0 (0.0) 461 0 (0.0) 
2009 
Influenza A 
(H1N1) 
670 5 (0.7) 191 0 (0.0) 
 
Additional neuraminidase inhibitor resistance testing is performed by a subset of public health 
laboratories and results of this testing are shared with CDC.  Currently, public health laboratories 
from three states (MD, MN, and WA) have submitted results of testing performed on specimens 
collected since October 1, 2010, and four (0.6%) of 665 2009 influenza A (H1N1) specimens tested 
indicated resistance to oseltamivir.  The specimens tested are from three states and may not be 
nationally representative. 
 
To prevent the spread of antiviral resistant virus strains, CDC reminds clinicians and the public of 
the need to continue hand and cough hygiene measures for the duration of any symptoms of 
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influenza, even while taking antiviral medications. Additional information on antiviral 
recommendations for treatment and chemoprophylaxis of influenza virus infection is available at 
http://www.cdc.gov/flu/antivirals/index.htm.   
  
 
Pneumonia and Influenza (P&I) Mortality Surveillance: During week 11, 8.6% of all deaths 
reported through the 122-Cities Mortality Reporting System were due to P&I. This percentage was 
above the epidemic threshold of 8.0% for week 11 and is the eighth consecutive week in which P&I 
has been at or above the epidemic threshold. 
 
Pneumonia and Influenza Mortality for 122 U.S. Cities 
Week ending 3/19/2011 
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Influenza-Associated Pediatric Mortality: Six influenza-associated pediatric deaths were reported 
to CDC during week 11. Two of these deaths were associated with influenza B viruses, two were 
associated with influenza A (H3N2) viruses, one was associated with 2009 influenza A (H1N1) 
virus, and one was associated with an influenza A virus for which the subtype was not determined. 
 
Seventy-seven deaths from 29 states (Arizona, California, Colorado, Florida, Georgia, Hawaii, 
Illinois, Indiana, Kentucky, Louisiana, Maine, Michigan, Minnesota, Nevada, New Jersey, New 
Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Texas, 
Utah, Vermont, Virginia, West Virginia, and Wisconsin) and Chicago and New York City have been 
reported during this influenza season. Twenty-nine of the 77 deaths reported were associated with 
influenza B viruses, 16 deaths reported were associated with influenza A (H3) viruses, 17 were 
associated with 2009 influenza A (H1N1) viruses, and 15 were associated with an influenza A virus 
for which the subtype was not determined.   
 
Number of Influenza-Associated Pediatric Deaths by Week of Death: 
2007-08 season to present 
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Week of Death
2007-08
Number of Deaths 
Reported = 88
2008-09
Number of Deaths 
Reported = 133
2009-10
Number of Deaths 
Reported = 282
Deaths Reported Current WeekDeaths Reported Previous Week
2010-11
Number of Deaths 
Reported =  77
 
 
Influenza-Associated Hospitalizations: FluSurv-NET conducts population-based surveillance for 
laboratory-confirmed influenza-associated hospitalizations in children (persons younger than 18 
years) and adults. The current network covers over 80 counties in the 10 Emerging Infections 
Program (EIP) states (CA, CO, CT, GA, MD, MN, NM, NY, OR, and TN) and six additional states 
(ID, MI, OH, OK, RI, and UT). 
 
The current season’s rates include cases from October 1, 2010 to March 19, 2011. 
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Please note the following: (i) The scale of the vertical axis on the Cumulative Hospitalization Rate figures will be adjusted 
during the season to make the graphs easier to read; (ii) FluSurv-NET was created during the 2009-2010 season when 
surveillance in six states was added to ongoing surveillance for influenza-associated hospitalizations in10 EIP states. 
During the 2009-2010 season, FluSurv-NET included sites in the 10 EIP sites and sites in IA, ID, MI, ND, OK, and SD; (iii) 
the 2008-2009 EIP season ended April 14, 2009, due to the onset of the 2009 H1N1 pandemic. 
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1
Asthma may include a diagnosis of asthma and reactive airway disease; Cardiovascular diseases may include conditions 
such as coronary heart disease, cardiac valve disorders, congestive heart failure, pulmonary hypertension, and aortic 
stenosis; Chronic lung diseases may include conditions such as bronchiolitis obliterans, chronic aspiration pneumonia, 
and interstitial lung disease; Immune suppression may include conditions such as immunoglobulin deficiency, leukemia, 
lymphoma, HIV/AIDS, and individuals taking immunosuppressive medications; Metabolic disorders may include conditions 
such as diabetes mellitus, thyroid dysfunction, adrenal insufficiency, and liver disease; Neurologic diseases may include 
conditions such as seizure disorders, neuromuscular disorders, and cognitive dysfunction; Obesity was defined as a body 
mass index (BMI) greater than 30 kg/m
2
 in patients 20 years of age or older, or equal to or greater than the 95
th
 percentile 
of a patient’s age and sex category in patients under 20 years of age; Renal diseases may include conditions such as 
acute or chronic renal failure, nephrotic syndrome, glomerulonephritis, and impaired creatinine clearance. 
2
Data as of March 22, 2011.  Includes 2,438 (of a total 4,931 reported) cases for which data collection has been 
completed through the medical chart review stage. 
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Demographic and clinical characteristics of laboratory-confirmed, influenza-
associated hospitalizations identified in EIP1 and FluSurv-NET2 sites, 2006-2011 
  2010-2011 
FluSurv-NET
3
 
N (%) 
2009-2010 
FluSurv-NET 
N (%) 
2008-2009 
EIP 
N (%) 
2007-2008 
EIP 
N (%) 
2006-2007 
EIP 
N (%) 
Total Cases 4,931 7,517 1,698 3,930 1,279 
Age in Years           
0-4 784 (15.9) 1,326 (17.6) 549 (32.3) 639 (16.3) 393 (30.7) 
5-17 355 (7.2) 1,204 (16.0) 244 (14.4) 221 (5.6) 130 (10.2) 
18-49 1,272 (25.8) 2,779 (37.0) 374 (22.0) 736 (18.7) 246 (19.2) 
50-64 945 (19.2) 1,458 (19.4) 201 (11.8) 585 (14.9) 155 (12.1) 
65+ 1,570 (31.8) 750 (10.0) 330 (19.4) 1,749 (44.5) 355 (27.8) 
Sex           
Male 2,280 (46.2) 3,517 (46.8) 832 (49.0) 1,825 (46.4) 631 (49.3) 
Female 2,639 (53.5) 4,000 (53.2) 866 (51.0) 2,104 (53.5) 648 (50.7) 
Flu Type and Subtype           
Influenza A 4,079 (82.7) 7,355 (97.8) 1,236 (72.8) 2,562 (65.2) 1,082 (84.6) 
       Specimens subtyped
4
 1,044 5,325 -- -- -- 
            A (H1) 0 (0.0) 0 (0.0) -- -- -- 
            A (H3) 692 (66.3) 3 (0.1) -- -- -- 
            A (2009 H1N1) 352 (33.7) 5,322 (99.9) -- -- -- 
Influenza B 729 (14.8) 52 (0.7) 382 (22.5) 1,199 (30.5) 149 (11.6) 
Intensive Care Unit 415 (17.0) 1,560 (20.8) 298 (17.6) 495 (12.6) 198 (15.5) 
Mechanical Ventilation 171 (7.0) 758 (10.1) 157 (9.2) 252 (6.4) 111 (8.7) 
Diagnosis of Pneumonia 664 (27.2) 2,804 (37.3) 407 (24.0) 1,220 (31.0) 404 (31.6) 
Died 51 (2.1) 222 (3.0) 49 (2.9) 104 (2.6) 24 (1.9) 
 
Columns may not sum to 100% due to missing or unknown values. 
1
Surveillance in EIP states (CA, CO, CT, GA, MD, MN, NM, NY, OR, TN) was conducted from 2006-2011. 
2
FluSurv-Net includes surveillance at EIP sites and at sites in additional states (IA, ID, MI, ND, OK, SD in 2009-2010; ID, 
MI, OH, OK, RI, UT in 2010-2011). 
3
Data as of March 22, 2011.  Results describing influenza A subtype, intensive care unit admission, mechanical 
ventilation, diagnosis of pneumonia, and death are from 2,438 (of a total 4,931 reported) cases for which data collection 
has been completed through the medical chart review stage. 
4
Influenza A subtype results are available beginning with the 2007-2008 season. Percentages for influenza A subtypes 
are calculated using the number of influenza A specimens that were subtyped as a denominator. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2010-11 Influenza Season – Week 11, ending March 19, 2011           
 
10 
 
Outpatient Illness Surveillance: Nationwide during week 11, 2.5% of patient visits reported 
through the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet) were due to 
influenza-like illness (ILI). This percentage is at the national baseline of 2.5%.  
 
Percentage of Visits for Influenza-like Illness (ILI) Reported by  
the U.S. Outpatient Influenza-like Illness Surveillance Network (ILINet), 
Weekly National Summary, September 30, 2007 – March 19, 2011 
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On a regional level, the percentage of outpatient visits for ILI ranged from 1.4% to 3.4% during 
week 11.  Six of the 10 regions (Regions 1, 2, 5, 7, 8, and 10) reported ILI at or above region-
specific baseline levels. 
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Region 6 - AR, LA, NM, OK, TX
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Region 2 - NJ, NY, USVI
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ILINet State Activity Indicator Map: Data collected in ILINet are used to produce a measure of ILI 
activity* by state. Activity levels are based on the percent of outpatient visits in a state due to ILI 
and are compared to the average percent of ILI visits that occur during spring and fall weeks with 
little or no influenza virus circulation. Activity levels range from minimal, which would correspond to 
ILI activity from outpatient clinics being below the average, to high, which would correspond to ILI 
activity from outpatient clinics being much higher than the average. Because the clinical definition of 
ILI is very general, not all ILI is caused by influenza; however, when combined with laboratory data, 
the information on ILI activity provides a clear picture of influenza activity in the United States. 
 
During week 11, the following ILI activity levels were experienced: 
 One state (Idaho) experienced high ILI activity. 
 Two states (West Virginia and Wisconsin) experienced moderate ILI activity. 
 Eleven states (Arkansas, Hawaii, Illinois, Indiana, Massachusetts, Nevada, New Mexico, 
North Dakota, Oklahoma, Utah, and Virginia) experienced low ILI activity. 
 Minimal ILI activity was experienced by New York City and 35 states (Alabama, Alaska, 
Arizona, California, Connecticut, Delaware, Florida, Georgia, Iowa, Kansas, Kentucky, 
Louisiana, Maine, Maryland, Michigan, Minnesota, Mississippi, Missouri, Montana, 
Nebraska, New Hampshire, New Jersey, New York, North Carolina, Ohio, Oregon, 
Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Vermont, 
Washington, and Wyoming). 
 The District of Columbia and one state (Colorado) had insufficient data to calculate an 
activity level. 
 
Interactive web tool available at: http://gis.cdc.gov/grasp/fluview/main.html 
*This map uses the proportion of outpatient visits to health care providers for influenza-like illness to measure the ILI activity level within a state. It does not, 
however, measure the extent of geographic spread of flu within a state. Therefore, outbreaks occurring in a single city could cause the state to display high 
activity levels. 
Data collected in ILINet may disproportionately represent certain populations within a state, and therefore, may not accurately depict the full picture of 
influenza activity for the whole state. 
Data displayed in this map are based on data collected in ILINet, whereas the State and Territorial flu activity map are based on reports from state and 
territorial epidemiologists. The data presented in this map is preliminary and may change as more data is received. 
Differences in the data presented by CDC and state health departments likely represent differing levels of data completeness with data presented by the 
state likely being the more complete.  
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Geographic Spread of Influenza as Assessed by State and Territorial Epidemiologists: The 
influenza activity reported by state and territorial epidemiologists indicates geographic spread of 
influenza viruses, but does not measure the severity of influenza activity. 
 
During week 11, the following influenza activity was reported: 
 Widespread influenza activity was reported by 18 states (Alaska, California, Connecticut, 
Idaho, Iowa, Maine, Massachusetts, Michigan, Minnesota, Montana, Nevada, New 
Hampshire, New York, Pennsylvania, Virginia, Washington, Wisconsin, and Wyoming). 
 Regional influenza activity was reported by 22 states (Arizona, Colorado, Georgia, Hawaii, 
Kansas, Kentucky, Louisiana, Maryland, Missouri, Nebraska, New Jersey, New Mexico, 
North Carolina, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Rhode 
Island, Texas, Vermont, and West Virginia). 
 Local influenza activity was reported by the District of Columbia and seven states (Alabama, 
Arkansas, Illinois, Mississippi, Oregon, Tennessee, and Utah). 
 Sporadic influenza activity was reported by Guam, Puerto Rico, the U.S. Virgin Islands and 
three states (Delaware, Florida, and Indiana). 
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Additional National and International Influenza Surveillance Information 
 
Distribute Project: Additional information on the Distribute syndromic surveillance project, 
developed and piloted by the International Society for Disease Surveillance (ISDS) now working in 
collaboration with CDC to enhance and support Emergency Department (ED) surveillance, is 
available at http://isdsdistribute.org/. 
 
Google Flu Trends: Google Flu Trends uses aggregated Google search data in a model created in 
collaboration with CDC to estimate influenza activity in the U.S. For more information and activity 
estimates from the U.S. and worldwide, see http://www.google.org/flutrends/. 
 
Europe: For the most recent influenza surveillance information from Europe, please see 
WHO/Europe at http://www.euroflu.org/index.php and visit the European Centre for Disease 
Prevention and Control at 
http://ecdc.europa.eu/en/publications/surveillance_reports/influenza/Pages/weekly_influenza_survei
llance_overview.aspx. 
 
Public Health Agency of Canada: The most up to date influenza information from Canada is 
available at http://www.phac-aspc.gc.ca/fluwatch/. 
 
World Health Organization FluNet: Additional influenza surveillance information from participating 
WHO member nations is available at http://gamapserver.who.int/GlobalAtlas/home.asp. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A description of surveillance methods is available at: http://www.cdc.gov/flu/weekly/overview.htm 
Report prepared: March 25, 2011. 
 
